- Medicine - Feb 23 New link between gut bacteria and obesity
- Medicine - Feb 23 Award to fund U-M food systems anemia research in Africa
- Medicine - Feb 23 Warning over claims that medical cannabis cuts opioid use
- Medicine - Feb 22 The myth of what’s driving the opioid crisis
- Medicine - Feb 22 Forecasting antibiotic resistance with a ’weather map’ of local data
- Medicine - Feb 22 New curriculum prioritizes tribal sovereignty, cultural respect in scientific research of American Indian, Alaska Native communities
- Medicine - Feb 22 Carbon monoxide detection in the body could lead to rapid disease diagnostics
- Business - Feb 22 Family Larsson- Rosenquist Foundation to Finance New Center for Research into Long- Term Effects of Breastfeeding
- Medicine - Feb 22 Treatment with Novartis’ Ultibro Breezhaler improved cardiac function in COPD patients with lung hyperinflation
- Careers - Feb 22 5 career barriers and how to break through them
- Veterinary Science - Feb 22 Australians support a whip ban in horse racing: poll
- Medicine - Feb 22 Securing a child’s future needs to start during parents’ teen years
- Medicine - Feb 21 Ebola vaccine inches toward human clinical trials
- Medicine - Feb 21 PremieBreathe gives premature babies a better chance
- Medicine - Feb 21 Generous donation benefits Yale psychosis treatment program
- Medicine - Feb 21 New Open- access Data Resource Aims to Bolster Collaboration in Global Infectious Disease Research
$42.9m to bolster UQ health research
University of Queensland research into dementia, cancer, superbugs, painkillers, and children’s health are among 51 projects that will benefit from National Health and Medical Research Council (NHMRC) 2018 Project Grant funding announced today.
The medical grants body’s $42.88 million allocation for UQ research projects is almost $10 million more than the $32.98 million it granted the University in 2017.
Vice-Chancellor and President Professor Peter Høj said UQ’s health research focused on practical solutions for medical conditions affecting millions of people around the world.
“The funding will support research into dementia diagnosis, intervention and care, work to develop non-opioid painkillers, and projects focussing on cancer, superbugs and the management of asthma in pregnancy,” Professor Høj said.
He said the significant rise in UQ’s NHMRC Project Grant funding was an affirming reflection of UQ’s researchers and their work.
“The NHMRC saw the potential for many of the UQ proposals to transform the way we treat disease,” he said.
He noted two of the grants were worth more than $2 million and 10 were for more than $1 million.
Close to half of UQ’s 2018 funding will go to the Faculty of Medicine , accounting for $20 million across 18 projects.
Another 10 projects at UQ’s Institute for Molecular Bioscience will share $7.8 million.
Queensland Brain Institute researchers have been awarded more than $6.4 million across 11 NHMRC project grants.
Professor Jürgen Götz received two grants totalling $1.2 million over four years to further explore ultrasound as a method to treat and prevent neurodegenerative disease, and to investigate the role of the molecule TYROBP in Alzheimer’s disease.
Associate Professor Tim Bredy received $531,978 to research DNA modifications underlying sex differences in fear-related learning and memory.
The full list of QBI project grants are here.
Faculty of Medicine intensive care specialist Professor Andreas Schibler received two grants totalling $4.5 million, including $2.63 million for research into acute respiratory failure - the most common reason children are admitted to hospital.
Professor Schibler hopes early intervention with new “nasal hi-flow” therapy to support breathing could reduce the number of children admitted to intensive care.
Professor Schibler also received $1.9 million for research into congenital heart disease - a leading cause of infant mortality in industrialised countries.
Dr Leanne Sakzewski in the Faculty of Medicine was awarded grants totalling $2.1 million for two projects that aim to improve movement and quality of life for children with cerebral palsy.
Funding to Institute for Molecular Bioscience research included $1.09 million for Professor Alpha Yap ’s work examining a newly discovered mechanism the body uses to protect itself from cancer.
Executive Dean of Science Professor Melissa Brown congratulated successful researchers, including six School of Chemistry and Molecular Biosciences-led projects.
“The NHMRC panels have appreciated the significance of the research projects being conducted on these globally important health and medical issues in the Science Faculty,” she said.
SCMB Head Professor Paul Young said School researchers would participate in 11 projects funded to $8.3 million, including six totalling $4.4 million led by School staff.
“This is an outstanding result - one more project grant to the School than last year - and includes two projects led by Dr Luke Guddat,” he said.
SCMB-led projects are:
leads a three-year $862,061 project on virus vaccines that ensure preparedness against future public health emergencies, such as Ebola virus, Middle East Respiratory Coronavirus, Nipah virus and Lassa fever virus;
leads projects developing new drug candidates for human tuberculosis ($680,585 over three years); and versatile drugs to treat infectious diseases ($755,585 over three years); and
leads a three-year, $549,936 project looking at a new generation of diagnostics and vaccines against mosquito-borne viral disease.
SCMB researchers will also participate in five projects on topics including designing novel and safe drugs to selectively target resistant tumours; studying how our innate immune system uses zinc to combat bacterial infections; killing infected cells to eradicate tuberculosis; identifying resistance mutations in a new class of drugs to treat TB; and developing novel TB drug candidates.
A full list of NHMRC Project Grant funding is here.
Images: (top) the UQ Faculty of Medicine building at Herston in Brisbane; above Vice-Chancellor Professor Peter Høj.
Last job offers
- Medicine/Pharmacology - 24.2
Wissenschaftliche/r Assistierende/r Pharmazeutische Technologie (80 %)
- Life Sciences - 22.2
Wissenschaftliche/n Mitarbeiter/in (50%)
- Life Sciences - 12.2
Post-Doctoral position in Cancer Epigenetics
- Life Sciences - 8.2
Adjunct Professor in Biology and Genetics
- Life Sciences - 1.2
Medizinische Informatiker /Bioinformatiker /Naturwissenschaftler (m/w)
- Life Sciences - 1.2
Einstieg für Naturwissenschaftler / Biologen in die IT-Consulting Welt
- Business/Economics - 23.2
Research Fellow - System Dynamics
- Medicine/Pharmacology - 23.2
Associate Professor in Medicinal Chemistry